Author:
Sun Yuanjue,Zhao Hui,Guo Yuewu,Lin Feng,Cai Xun,Tang Xiaochun,Yao Yang
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Yao Y. The diagnosis and comprehensive treatment of malignant tumour. Shanghai: Fudan University Press, 2005. 317.
2. Rothenberg ML, Oza AM, Bigelow RH, et al. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol, 2003, 21: 2049–2051.
3. Rougier P, Lepille D, Bennouma J, et al. Antitumor activity of three second-lline treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study. Ann Oncol, 2002, 13: 1558–1567.
4. Zhao H, Tao J, Sun YJ, et al. The effects of combination chemotherapy of hydroxycampothecin with oxaliplatin on human colorectal cancer cell line. Tumor (Chinese), 2005, 25: 416–419.
5. Zhang R, Li Y, Cai Q, et al. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I. Cancer Chemother Pharmacol, 1998, 41: 257–267.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献